
|Videos|March 9, 2015
Improving the Relationship Between Manufacturers and Specialty Pharmacies
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.
Advertisement
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
2
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
3
Neladalkib Shows Durable Responses in Heavily Pretreated ALK-Positive Lung Cancer
4
November 2025 Pharmacy Policy Updates
5















































































































































































































